Literature DB >> 19403552

A preliminary investigation of a novel design of visual cue glasses that aid gait in Parkinson's disease.

J H McAuley1, P M Daly, C R Curtis.   

Abstract

OBJECTIVE: Parkinson's disease is a relatively common progressive neurodegenerative disorder, one of whose main features is difficulty with walking. This can be partially corrected by providing cues for the placement of each step. We piloted the potential benefit of simple custom-designed 'walking glasses' worn by the patient that provide visual and auditory cues to aid in step placement.
DESIGN: We used a repeated measures design to compare gait performance when unaided and when using the walking glasses with different patterns of visual and auditory stimulation by timing patients' walking over a 'real-life' predefined 30-m course.
SETTING: Hospital outpatient clinic.
SUBJECTS: Fifteen patients with idiopathic Parkinson's disease who had significant gait problems and no other condition affecting gait performance. MAIN MEASURES: Timed walk.
RESULTS: Using the glasses, 8 of 15 patients achieved a significant and meaningful average improvement in walking time of at least 10% (mean (95% confidence interval) improvement in these patients was 21.5% (3.9%)), while a further 2 had subjective and modest objective benefit. Different patterns of visual and auditory cues suited different patients. Visual cueing alone with a fixed horizontal cue line present all the time statistically resulted in the greatest improvement in walking time.
CONCLUSIONS: This pilot study shows promising improvement in the gait of a significant proportion of Parkinson's disease patients through the use of a simple, inexpensive and robust design of walking glasses, suggesting practical applicability in a therapy setting to large numbers of such patients.

Entities:  

Mesh:

Year:  2009        PMID: 19403552     DOI: 10.1177/0269215509104170

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  9 in total

1.  Recent advances in the assessment and treatment of falls in Parkinson's disease.

Authors:  Anke H Snijders; Jorik Nonnekes; Bastiaan R Bloem
Journal:  F1000 Med Rep       Date:  2010-10-21

2.  Use of Mobile Device Accelerometry to Enhance Evaluation of Postural Instability in Parkinson Disease.

Authors:  Sarah J Ozinga; Susan M Linder; Jay L Alberts
Journal:  Arch Phys Med Rehabil       Date:  2016-09-23       Impact factor: 3.966

3.  Impaired Switching from Self-Prepared Actions in Mild Parkinson Disease.

Authors:  Matthew L Cohen; Nadine A Schwab; Catherine C Price; Kenneth M Heilman
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

4.  Sensory Electrical Stimulation Cueing May Reduce Freezing of Gait Episodes in Parkinson's Disease.

Authors:  Lois Rosenthal; Dean Sweeney; Anne-Louise Cunnington; Leo R Quinlan; Gearóid ÓLaighin
Journal:  J Healthc Eng       Date:  2018-08-01       Impact factor: 2.682

5.  Crossing Virtual Doors: A New Method to Study Gait Impairments and Freezing of Gait in Parkinson's Disease.

Authors:  Luis I Gómez-Jordana; James Stafford; C Lieke E Peper; Cathy M Craig
Journal:  Parkinsons Dis       Date:  2018-08-09

6.  Using Kinect v2 to Control a Laser Visual Cue System to Improve the Mobility during Freezing of Gait in Parkinson's Disease.

Authors:  Amin Amini; Konstantinos Banitsas
Journal:  J Healthc Eng       Date:  2019-02-20       Impact factor: 2.682

7.  Holocue: A Wearable Holographic Cueing Application for Alleviating Freezing of Gait in Parkinson's Disease.

Authors:  Daphne J Geerse; Bert Coolen; Jacobus J van Hilten; Melvyn Roerdink
Journal:  Front Neurol       Date:  2022-01-10       Impact factor: 4.003

Review 8.  Recent Advancements in Electrochemical Biosensors for Monitoring the Water Quality.

Authors:  Yun Hui; Zhaoling Huang; Md Eshrat E Alahi; Anindya Nag; Shilun Feng; Subhas Chandra Mukhopadhyay
Journal:  Biosensors (Basel)       Date:  2022-07-21

9.  Feasibility of external rhythmic cueing with the Google Glass for improving gait in people with Parkinson's disease.

Authors:  Yan Zhao; Jorik Nonnekes; Erik J M Storcken; Sabine Janssen; Erwin E H van Wegen; Bastiaan R Bloem; Lucille D A Dorresteijn; Jeroen P P van Vugt; Tjitske Heida; Richard J A van Wezel
Journal:  J Neurol       Date:  2016-04-25       Impact factor: 4.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.